Vasonatrite (naftidrofuryl)
Peripheral arterial disease
ApprovedActive
Key Facts
About OM Pharma
OM Pharma is a long-established Swiss biopharmaceutical company with a specialized focus on bacterial immunotherapies for infection prevention and vascular diseases. Its core business model revolves around developing and commercializing immunomodulatory products, primarily derived from bacterial lysates, to train the immune system. The company has a global commercial footprint with a portfolio of approved products, positioning it in the 'Commercial' stage. As a private company, it leverages decades of experience in microbial-based therapeutics.
View full company profileTherapeutic Areas
Other Peripheral arterial disease Drugs
| Drug | Company | Phase |
|---|---|---|
| ADSC Therapy for Critical Limb Ischemia | A4Cell | Pre-clinical |